Barry J. Make

1 month ago | digitalcommons.library.tmc.edu | Edwin K. Silverman |Arthur Kim |Barry J. Make |Elizabeth Regan

AbstractThe consequences of returning infectious pathogen test results identified incidentally in research studies have not been well-studied. Concerns include identification of an important health issue for individuals, accuracy of research test results, public health impact, potential emotional distress for participants, and need for IRB permissions.

Sep 1, 2023 | openres.ersjournals.com | Anthony N. Gerber |Barry J. Make |Michael E. Wechsler |R. Lee Reinhardt

IntroductionVaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) targeting the ancestral (Wuhan-Hu-1/2019) viral spike (S) protein has been broadly effective at limiting infection and severe coronavirus disease 2019 (COVID-19) [1–6]. With respect to SARS-CoV-2 infection, both the humoral and cell-mediated arms of the adaptive response are important for achieving optimal control of COVID-19 [7].